Načítá se...
Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab
Patient: Male, 57-year-old Final Diagnosis: Febrile neutropenia Symptoms: Fever Medication: Nivolumab Clinical Procedure: Chemotherapy Specialty: Oncology OBJECTIVE: Adverse events of drug therapy BACKGROUND: Nivolumab is a human IgG4 monoclonal antibody against human programmed cell death 1 (PD-1)....
Uloženo v:
| Vydáno v: | Am J Case Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Scientific Literature, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7020738/ https://ncbi.nlm.nih.gov/pubmed/32018275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AJCR.920809 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|